PMCF Study on the Safety, Performance and Clinical Benefits Data of the Zimmer® Plates and Screws System
PMCF Study to Provide Safety, Performance and Clinical Benefits Data of the Zimmer® Plates and Screws System Applied for Diaphyseal, Proximal Humerus and Proximal Tibia Fractures (Implants and Instrumentation) - A Retro- and Prospective Consecutive Series Study
1 other identifier
observational
57
1 country
1
Brief Summary
The study is a monocentric, retro- and prospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to confirm safety, performance and clinical benefits of the Zimmer® Plates and Screws System (implants and instrumentation) when used to stabilize diaphyseal, proximal humerus and proximal tibia fractures. The primary objective is the assessment of performance by analyzing fracture healing. The secondary objectives are the assessment of safety by recording and analyzing the incidence and frequency of complications and adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified. Subjects' outcomes will also be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2022
CompletedFirst Posted
Study publicly available on registry
January 31, 2022
CompletedStudy Start
First participant enrolled
March 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2024
CompletedResults Posted
Study results publicly available
February 25, 2025
CompletedFebruary 25, 2025
November 1, 2024
1 year
January 28, 2022
November 8, 2024
February 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Performance: Fracture Healing
Performance will be assessed by analyzing fracture healing radiographically or clinically. Timepoints at which the data will be collected will be summarized through means.
At last consultation visit either at minimum 6 months post-operative by radiographic assessment or, if no x-rays available, by clinical assessment at the follow-up phone call at minimum 1 year postoperative.
Secondary Outcomes (4)
Product Safety (Number of Adverse Events, Serious Adverse Events, Adverse Device Effects and Serious Adverse Device Effects)
At operative evaluation, immediate post-operative evaluation, last consultation visit at minimum 6 months post-operative and at the follow-up phone call at minimum 1 year postoperative.
Tegner Lysholm Knee Score (Proximal Tibia)
Final follow-up visit at minimum 1 year postoperative.
Oxford Shoulder Score (OSS) (Proximal Humerus)
Final follow-up visit at minimum 1 year postoperative.
EuroQol Five-dimensional Health Questionnaire (EQ-5D-5L) (Diaphysis)
Final follow-up visit at minimum 1 year postoperative.
Study Arms (1)
Patients implanted with the Zimmer® Plates and Screws System
Patients who already received the Zimmer® Plates and Screws System in the Diaphysis, Proximal Humerus and Proximal Tibia.
Eligibility Criteria
Consecutive series of cases implanted with plates and screws belonging to the Zimmer® Plates and Screws System according to Zimmer Biomet's Instruction for Use (IFU) and who meet the inclusion criteria and none of the exclusion criteria.
You may qualify if:
- Patients having received one of the plates belonging to the Zimmer® Plates and Screws System, designed for temporary internal fixation to stabilize fractures during the normal healing process. In this study we will collect data specifically on Zimmer® Plates and Screws System plates belonging to the Diaphysis, Proximal Humerus and Proximal Tibia groups.
You may not qualify if:
- Off-label use
- Patients under the age of 18
- Prisoners
- Severely comminuted fractures in which bone fragments are too small or numerous to adequately fix or maintain a reduced position
- Infection
- Metal sensitivity or intolerance
- Severe osteopenia and/or osteoporosis, or in the presence of marked or rapid bone absorption, metabolic bone disease, cancer, or any other tumor-like condition of the bone which may compromise fixation
- Sternal or spinal fractures
- Anatomical location in which the device would interfere with nerves, blood vessels, or other vital structures
- Patients with inadequate soft tissue coverage at the implant site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zimmer Biometlead
Study Sites (1)
SC Clinica Ortopedica e Traumatologica II IRCCS Istituto Ortopedico Rizzoli
Bologna, 40136, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
A limitation to this study is its retrospective design. Due to this, no patients implanted with a Zimmer® Plates and Screws System plate in the proximal humerus could be enrolled in this study.
Results Point of Contact
- Title
- Andrea Singer
- Organization
- Zimmer Biomet
Study Officials
- STUDY DIRECTOR
Hassan Achakri
Zimmer Biomet
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2022
First Posted
January 31, 2022
Study Start
March 15, 2023
Primary Completion
March 27, 2024
Study Completion
March 27, 2024
Last Updated
February 25, 2025
Results First Posted
February 25, 2025
Record last verified: 2024-11